He also serves as Chief of the Beta Cell Biology Unit (Diabetes Research Institute), and Director of Human Islet Processing Facility, and coordinator of European Consortium for Islet Transplantation that has been providing Human beta Cell Products for research and clinical applications at HSR, in Italy and across state barriers in Europe since 2000 (See European Consortium for Islet Transplantation).
Prof Piemonti is also Adjunct Professor at University “Vita Salute San Raffaele” of Milan and as Honorary Visiting Professor at Vrije Universiteit of Brussel. Mainof expertise is mainly focused on diabetes and pancreatology, in particular he has large experience about diabetes and pancreatic cancer. He also in the past studied the role of innate immunity in islet cell biology (especially in the human model of islet transplantation in type 1 diabetes recipient) and in pancreatic cancer biology (especially the role of chemokines and chemokine receptor
system in inducing leukocytes infiltration). In addition, his research interests include beta cell replacement, immune tolerance induction strategies, dendritic cell biology, stem cells. I currently serve as section Editor of Cell Transplantation-the Regenerative Medicine Journal and of Current Diabetes Reports, as editorial board of Acta Dibetologia, as Councilor of the International Pancreas and Islet Transplantation Association (IPITA) of The Transplantation Society (TTS) and as member of the European Pancreas and Islet Transplantation Association (EPITA) committee of European Society for Organ Transplantation (ESOT).